Show simple item record

dc.contributor.authorGauvin, Robert
dc.contributor.authorGuillemette, Maxime D.
dc.contributor.authorKhademhosseini, Ali
dc.contributor.authorDokmeci, Mehmet R.
dc.date.accessioned2012-02-02T20:39:40Z
dc.date.available2012-02-02T20:39:40Z
dc.date.issued2011-10
dc.identifier.issn2045-824X
dc.identifier.urihttp://hdl.handle.net/1721.1/69018
dc.description.abstractRecent advances in medicine and healthcare allow people to live longer, increasing the need for the number of organ transplants. However, the number of organ donors has not been able to meet the demand, resulting in an organ shortage. The field of tissue engineering has emerged to produce organs to overcome this limitation. While tissue engineering of connective tissues such as skin and blood vessels have currently reached clinical studies, more complex organs are still far away from commercial availability due to pending challenges with in vitro engineering of 3D tissues. One of the major limitations of engineering large tissue structures is cell death resulting from the inability of nutrients to diffuse across large distances inside a scaffold. This task, carried out by the vasculature inside the body, has largely been described as one of the foremost important challenges in engineering 3D tissues since it remains one of the key steps for both in vitro production of tissue engineered construct and the in vivo integration of a transplanted tissue. This short review highlights the important challenges for vascularization and control of the microcirculatory system within engineered tissues, with particular emphasis on the use of microfabrication approaches.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (EB008392)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (HL092836)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (HL099073)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (EB009196)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (DE019024)en_US
dc.description.sponsorshipNational Science Foundation (U.S.) (DMR0847287)en_US
dc.description.sponsorshipUnited States. Army Research Office (Institute for Soldier Nanotechnologies)en_US
dc.description.sponsorshipUnited States. Office of Naval Researchen_US
dc.description.sponsorshipUnited States. Army. Corps of Engineersen_US
dc.publisherBioMed Central Ltden_US
dc.relation.isversionofhttp://dx.doi.org/10.1186/2045-824X-3-24en_US
dc.rightsCreative Commons Attributionen_US
dc.rights.urihttp://creativecommons.org/licenses/by/2.0en_US
dc.sourceBioMed Central Ltden_US
dc.titleApplication of microtechnologies for the vascularization of engineered tissuesen_US
dc.typeArticleen_US
dc.identifier.citationGauvin, Robert et al. “Application of Microtechnologies for the Vascularization of Engineered Tissues.” Vascular Cell 3.1 (2011): 24.en_US
dc.contributor.departmentHarvard University--MIT Division of Health Sciences and Technologyen_US
dc.contributor.departmentKoch Institute for Integrative Cancer Research at MITen_US
dc.contributor.mitauthorGauvin, Robert
dc.contributor.mitauthorGuillemette, Maxime D.
dc.contributor.mitauthorDokmeci, Mehmet
dc.contributor.mitauthorKhademhosseini, Ali
dc.relation.journalVascular Cellen_US
dc.eprint.versionFinal published versionen_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2011-12-12T20:06:31Z
dc.language.rfc3066en
dc.rights.holderGauvin et al.; licensee BioMed Central Ltd.
dspace.orderedauthorsGauvin, Robert; Guillemette, Maxime; Dokmeci, Mehmet; Khademhosseini, Alien
mit.licensePUBLISHER_CCen_US
mit.metadata.statusComplete


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record